Increased CXCL10 (IP-10) is associated with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models
-
Published:2024-07
Issue:
Volume:135
Page:104246
-
ISSN:0301-472X
-
Container-title:Experimental Hematology
-
language:en
-
Short-container-title:Experimental Hematology
Author:
Belmonte Miriam,
Cabrera-Cosme Lilia,
Øbro Nina F.ORCID,
Li Juan,
Grinfeld Jacob,
Milek Joanna,
Bennett EllieORCID,
Irvine MelissaORCID,
Shepherd Mairi S.,
Cull Alyssa H.,
Boyd Grace,
Riedel Lisa M.,
Chi Che James Lok,
Oedekoven Caroline A.,
Baxter E. Joanna,
Green Anthony R.,
Barlow Jillian L.,
Kent David G.ORCID
Reference49 articles.
1. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases;Panteli;Br J Haematol,2005
2. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study;Tefferi;J Clin Oncol,2011
3. Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F;Boissinot;Oncogene,2011
4. The systemic profile of soluble immune mediators in patients with myelodysplastic syndromes;Kittang;Int J Mol Sci,2016
5. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia;Kornblau;Blood,2010